More about the YSPH Covid-19 Pandemic Response

A mobile laboratory-in-a-van that brings testing services to underserved Connecticut neighborhoods is enabling Yale Pathology of Yale School of Medicine to establish relationships and build trust with community organizations.

A new COVID-19 variant nicknamed FLiRT is threatening to cause a summer wave of COVID infections.

As a health care entrepreneur and leader in the White House’s development of some of the most important health care initiatives of the 21st century, Andy Slavitt helped implement the Affordable Care Act and advised the Biden administration on its COVID-19 response. In a recent visit to YSPH, Slavitt shared some of his key communications practices as part of the Leaders in Public Health speakers series.

Dean Megan L. Ranney speaks with former U.S. Secretary of Health and Human Services Alex M. Azar II

Harlan Krumholz, MD, Harold H. Hines, Jr. Professor of Medicine (Cardiology), and Akiko Iwasaki, PhD, Sterling Professor of Immunobiology and professor of dermatology; of molecular, cellular and developmental biology; and of epidemiology (microbial diseases), discuss the association between long COVID and age, sex, race, and ethnicity.

An annual COVID-19 vaccination campaign, in which second doses were administered to certain at-risk populations, was associated with reduced disease burden and health care costs, according to a new study led by researchers at the Yale School of Public Health.

Most analyses regarding the excess risk of death during the COVID-19 pandemic have relied on summary data. However, a recent study published in the International Journal of Epidemiology instead analyzed individual patient-level data based on medical records from the largest integrated healthcare system in the United States.

A new COVID-19 variant known as JN.1 is rapidly spreading across the United States and Europe as we head into peak holiday season travel time. Dr. Michael Cappello, MD, chair of the Yale School of Public Health’s Department of Epidemiology (Microbial Diseases), discusses the new variant, its threat potential, and what people can do to protect themselves from infection.

With SARS-COV-2 infection rates rising again, you may be wondering if you should get a COVID-19 vaccine booster shot. Yale physicians have built a tool to help answer these questions.